SEATTLE: A patient’s very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases.
By 2020, neurological conditions will become the leading cause of death and disability.
Patients’ skin cells will be reprogramd into induced pluripotent stem cells (iPSCs) and then differentiated into disease relevant cells for research.
The initial targets in the platform will be ALS and Parkinson’s disease…